Search results
Q&A: AstraZeneca's COVID-19 vaccine and blood clots—what you need to know
Medical Xpress· 18 hours agoPharmaceutical giant AstraZeneca admitted in court this week that its COVID-19 vaccine can cause a...
Pfizer Stock Gets Boost From Better-Than-Expected Earnings
Investopedia· 17 hours agoThe company posted adjusted net income, which doesn't account for items such as impact of...
Flu vs COVID: Stark Disparity in Vaccination and Deaths
Medscape· 5 hours agoIn the first half of 2023, COVID-19 killed 42,670 people in the United States, while the flu killed...
GlaxoSmithKline Sues Pfizer and BioNTech Over Covid-19 Vaccine Technology
US News & World Report· 7 days agoUS News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news ...
Study confirms effectiveness of bivalent COVID-19 vaccine
Medical Xpress· 7 days agoThis was the first research project conducted to evaluate the immunity induced by the Pfizer...
Pfizer beats earnings estimates months after stock dipped to record lows
Crain's New York Business· 12 hours agoWhen excluding Pfizer’s Covid products, revenues increased 11%, indicating the success of its $43 billion acquisition of oncology firm Seagen and sales ...
Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To...
Benzinga via AOL· 18 hours agoOn Wednesday, Pfizer Inc. (NYSE:PFE) reported first-quarter adjusted EPS of $0.82, down 33% year...
Pfizer Stock Rises as Outlook Rises After Earnings Beat
Barrons.com· 21 hours agoPfizer bumped up its earnings guidance on Wednesday while reporting better financial results than...
Pfizer stock gains 7% after earnings beat, company calls dividend 'secure'
AOL· 17 hours agoPfizer (PFE) beat on earnings in the first quarter of 2024, giving its stock a much-needed 7% boost Wednesday. Without its COVID products, the company is ...
Pfizer’s strong Vyndaqel sales draw attention to rare disease drug’s patent life
BioPharma Dive via Yahoo Finance· 22 hours agoSales of the transthyretin amyloidosis treatment widely beat Wall Street forecasts in the first...